Volume | 13,420 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 2.95 | Mínimo Máximo |
|||||
Minimo del Dia | 2.5567 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Anebulo Pharmaceuticals Inc | ANEB | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.61 | 2.5567 | 2.95 | 2.80 | 2.64 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
159 | 13,420 | US$ 2.70 | US$ 36,275 | - | 1.62 - 4.05 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
16:54:05 | 40 | US$ 2.66 | USD |
Información Financiera Anebulo Pharmaceuticals Inc ANEB
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
72.61M | 25.93M | - | 0 | -11.73M | -0.45 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Anebulo Pharmaceuticals Inc ANEB
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
17/6/2024 | 15:23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
17/6/2024 | 15:23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
17/6/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
15/5/2024 | 15:31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15/5/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
15/5/2024 | 12:05 | Business Wire | Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year.. |
13/2/2024 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/2/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 15:05 | Business Wire | Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year.. |
21/11/2023 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
14/11/2023 | 15:05 | Business Wire | Anebulo Pharmaceuticals Reports First Quarter Fiscal Year.. |
30/10/2023 | 08:31 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
Histórico de Datos ANEB
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.02 | 2.9598 | 1.80 | 2.64 | 37,204 | 0.78 | 38.61% |
1 Month | 2.07 | 2.9598 | 1.80 | 2.53 | 9,755 | 0.73 | 35.27% |
3 Months | 2.785 | 3.30 | 1.80 | 2.60 | 7,173 | 0.015 | 0.54% |
6 Months | 2.49 | 3.30 | 1.80 | 2.57 | 7,411 | 0.31 | 12.45% |
1 Year | 2.08 | 4.05 | 1.62 | 2.50 | 10,292 | 0.72 | 34.62% |
3 Years | 7.14 | 7.885 | 1.62 | 3.62 | 8,136 | -4.34 | -60.78% |
5 Years | 7.38 | 9.33 | 1.62 | 4.54 | 10,362 | -4.58 | -62.06% |